Literature DB >> 19248547

Bioptics with LASIK flap first for the treatment of high ametropia.

Merab L Dvali1, Nana A Tsinsadze, Bella V Sirbiladze.   

Abstract

PURPOSE: To report the safety and predictability of an alternate sequence of the bioptics procedure.
METHODS: In this prospective study of 50 eyes, phakic intraocular lenses (IOLs) and pseudophakic IOLs were implanted, followed by LASIK. The corneal flap was created, followed by lens implantation 3 days later. Laser ablation was performed to the stromal bed 3 months later. Fifty eyes with varying degrees of refractive error (range of manifest refraction spherical equivalent [MRSE], -19.50 to +8.50 diopters [D]) were treated. Follow-up ranged from 3 months to 4 years postoperatively.
RESULTS: No intra- or postoperative complications occurred. Postoperatively, MRSE ranged from -0.75 to +0.50 D. Mean residual refractive astigmatism ranged from +0.25 to +1.50 D postoperatively. Postoperative uncorrected visual acuity was 20/20 or better in 82% (41/50) of eyes and 20/40 or better in 98% (49/50) of eyes. No eyes experienced a loss of best spectacle-corrected visual acuity postoperatively.
CONCLUSIONS: This modification of the sequence of procedures for bioptics provided safe and predictable outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19248547     DOI: 10.3928/1081597X-20090115-15

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Clear lens extraction for patients who are unfit for laser-assisted in situ keratomileusis and implantable contact lenses in central Indian population.

Authors:  Rajesh Subhash Joshi
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

2.  Visual Outcomes After Sequential Posterior Chamber Phakic IOL with Corneal Refractive Surgery (Bioptics) for the Treatment of Myopic Astigmatism.

Authors:  Majid Moshirfar; Robert J Thomson; William B West Jnr; Shannon E McCabe; Thomas M Sant; Margaret H Shmunes; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Clin Ophthalmol       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.